Company
Headquarters: Beijing, China
Employees: 3,005
CN¥24.05 Billion
CNY as of Jan. 1, 2025
US$3.30 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥51.19 B |
| EBITDA | CN¥2.99 B |
| Gross Profit TTM | CN¥3.83 B |
| Profit Margin | 4.23% |
| Operating Margin | 4.26% |
| Quarterly Revenue Growth | 7.10% |
China National Medicines Corp Ltd has the following listings and related stock indices.
Stock: SSE: 600511 wb_incandescent